-
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
-
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs – Invitation to Business Update on April 17, 2024
-
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
-
Ultimovacs ASA: Mandatory notification of trade by primary insider
-
Ultimovacs ASA: Annual Report 2023
-
Ultimovacs ASA: Mandatory notification of trades by primary insider
-
Ultimovacs ASA: Mandatory notification of trades by primary insider
